China 3-Fluoro-4-nitrophenol Factory

To create much more benefit for consumers is our company philosophy; customer growing is our working chase for 3-Fluoro-4-nitrophenol,CAS NO 394-41-2,394-41-2,Regorafenibe intermediate,Regorafenib advance intermediate, Welcoming interested companies to cooperate with us, we look forward to having the opportunity of working with companies around the world for joint growth and mutual success.
3-Fluoro-4-nitrophenol, We set a strict quality control system. We have return and exchange policy, and you can exchange within 7 days after receive the wigs if it is in new station and we service repairing free for our products. Remember to feel free to contact us for further information and we will provide you competitive price list then.

Hot Products

  • 2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine

    2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine

    Product Name:2',3'-Di-O-acetyl-5'-deoxy-5-fuluro-D-cytidine
    Molecular Formula:C13H16FN3O6
    Molecular Weight:329.28
    CAS Registry Number:161599-46-8
  • Grapiprant

    Grapiprant

    Product Name:Grapiprant
    Molecular Formula:C26H29N5O3S
    Molecular Weight;491.61
    CAS Registry Number;415903-37-6
  • Azacytidine

    Azacytidine

    Product Name:Azacytidine
    Molecular Formula:C8H12N4O5
    Molecular Weight;244.2
    CAS Registry Number;320-67-2
  • Pramipexole dihydrochloride monohydrate

    Pramipexole dihydrochloride monohydrate

    Product Name:Pramipexole dihydrochloride monohydrate
    Molecular Formula:C10H20ClN3OS
    Molecular Weight;265.8
    CAS Registry Number;191217-81-9
  • 3-Fluoroanisole

    3-Fluoroanisole

    Product Name:3-Fluoroanisole
    Molecular Formula:C7H7FO
    Molecular Weight:126.13
    CAS Registry Number:456-49-5
  • Bupivacaine

    Bupivacaine

    Product Name:Bupivacaine
    Molecular Formula:C18H28N2O
    Molecular Weight;288.43
    CAS Registry Number;2180-92-9

Send Inquiry

X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept